Cite
MLA Citation
Joanna C. Masters et al.. “Model‐informed drug development supporting the approval of the avelumab flat‐dose regimen in patients with advanced renal cell carcinoma.” CPT: pharmacometrics & systems pharmacology, vol. 11, 2022, pp. 458–468. http://access.bl.uk/ark:/81055/vdc_100153772000.0x000004